Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA.

Morera DS, Lahorewala SS, Belew D, Ghosh S, Klaassen Z, Jordan AR, Wang J, Terris MK, Bollag RJ, Merseburger AS, Stenzl A, Soloway MS, Lokeshwar VB.

J Urol. 2019 May 21:101097JU0000000000000351. doi: 10.1097/JU.0000000000000351. [Epub ahead of print]

PMID:
31112107
2.

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model.

Piranlioglu R, Lee E, Ouzounova M, Bollag RJ, Vinyard AH, Arbab AS, Marasco D, Guzel M, Cowell JK, Thangaraju M, Chadli A, Hassan KA, Wicha MS, Celis E, Korkaya H.

Nat Commun. 2019 Mar 29;10(1):1430. doi: 10.1038/s41467-019-09015-1.

3.

Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.

Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB, Villanueva M, von Rundstedt FC, Karanam B, Ballester LY, Terris MK, Bollag RJ, Lerner SP, Apolo AB, Villanueva H, Lee M, Sikora AG, Lotan Y, Sreekumar A, Coarfa C, Putluri N.

Clin Cancer Res. 2019 Jun 15;25(12):3689-3701. doi: 10.1158/1078-0432.CCR-18-1515. Epub 2019 Mar 7.

PMID:
30846479
4.

Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.

Amara CS, Ambati CR, Vantaku V, Badrajee Piyarathna DW, Donepudi SR, Ravi SS, Arnold JM, Putluri V, Chatta G, Guru KA, Badr H, Terris MK, Bollag RJ, Sreekumar A, Apolo AB, Putluri N.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):770-781. doi: 10.1158/1055-9965.EPI-18-0936. Epub 2019 Jan 14.

PMID:
30642841
5.

Corrigendum to "CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma" Neoplasia, October 2018, Volume 20, Issue 10, Pages 1070-1082.

Angara K, Borin TF, Rashid MH, Lebedyeva I, Ara R, Lin PC, Iskander A, Bollag RJ, Achyut BR, Arbab AS.

Neoplasia. 2019 Jan;21(1):156-157. doi: 10.1016/j.neo.2018.11.001. No abstract available.

6.

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.

Angara K, Borin TF, Rashid MH, Lebedyeva I, Ara R, Lin PC, Iskander A, Bollag RJ, Achyut BR, Arbab AS.

Neoplasia. 2018 Oct;20(10):1070-1082. doi: 10.1016/j.neo.2018.08.011. Erratum in: Neoplasia. 2019 Jan;21(1):156-157.

7.

The growth of first-time blood bank board examinees exceeds that of other pathology subspecialties in the United States, 2007-2016.

Jajosky RP, Jajosky AN, Shikle JF, Bollag RJ.

Transfus Apher Sci. 2017 Oct;56(5):742-743. doi: 10.1016/j.transci.2017.09.002. Epub 2017 Sep 14. No abstract available.

PMID:
28958856
8.

A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.

Jajosky RP, Lumm WC, Wise SC, Bollag RJ, Shikle JF.

Immunohematology. 2017 Jun;33(2):73-75.

PMID:
28657766
9.

Hematologic complications in a patient with Glycine soja polyagglutination following fresh frozen plasma transfusion.

Jajosky RP, Cook LO, Manaloor E, Shikle JF, Bollag RJ.

Immunohematology. 2017 Jun;33(2):51-55.

PMID:
28657762
10.

NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression.

Simon PS, Bardhan K, Chen MR, Paschall AV, Lu C, Bollag RJ, Kong FC, Jin J, Kong FM, Waller JL, Pollock RE, Liu K.

Oncotarget. 2016 Apr 26;7(17):23395-415. doi: 10.18632/oncotarget.8246.

11.

Chemically Defined and Xeno-Free Cryopreservation of Human Adipose-Derived Stem Cells.

López M, Bollag RJ, Yu JC, Isales CM, Eroglu A.

PLoS One. 2016 Mar 24;11(3):e0152161. doi: 10.1371/journal.pone.0152161. eCollection 2016.

12.

A Federated Network for Translational Cancer Research Using Clinical Data and Biospecimens.

Jacobson RS, Becich MJ, Bollag RJ, Chavan G, Corrigan J, Dhir R, Feldman MD, Gaudioso C, Legowski E, Maihle NJ, Mitchell K, Murphy M, Sakthivel M, Tseytlin E, Weaver J.

Cancer Res. 2015 Dec 15;75(24):5194-201. doi: 10.1158/0008-5472.CAN-15-1973. Review.

13.

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartlett J, Bastacky S, Bergsten J, Blute ML, Boice L, Bollag RJ, Boyd J, Castle E, Chen YB, Cheville JC, Curley E, Davies B, DeVolk A, Dhir R, Dike L, Eckman J, Engel J, Harr J, Hrebinko R, Huang M, Huelsenbeck-Dill L, Iacocca M, Jacobs B, Lobis M, Maranchie JK, McMeekin S, Myers J, Nelson J, Parfitt J, Parwani A, Petrelli N, Rabeno B, Roy S, Salner AL, Slaton J, Stanton M, Thompson RH, Thorne L, Tucker K, Weinberger PM, Winemiller C, Zach LA, Zuna R.

N Engl J Med. 2016 Jan 14;374(2):135-45. doi: 10.1056/NEJMoa1505917. Epub 2015 Nov 4.

14.
15.

6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.

Shen H, Morrison CD, Zhang J, Underwood W 3rd, Yang N, Frangou C, Eng K, Head K, Bollag RJ, Kavuri SK, Rojiani AM, Li Y, Yan L, Hill A, Woloszynska-Read A, Wang J, Liu S, Trump DL, Candace JS.

Oncotarget. 2013 Nov;4(11):2124-34.

16.

Characterization of rare mammary tumours appearing on the neck of RIII/Sa mice infected with mouse mammary tumour virus.

Sarkar NH, Borke JL, Bollag RJ.

J Comp Pathol. 2013 Jul;149(1):40-7. doi: 10.1016/j.jcpa.2012.11.238. Epub 2013 Jan 23.

PMID:
23351506
17.

Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia.

Bollag RJ, Sterett M, Reding MT, Key NS, Cohn CS, Ustun C.

Eur J Haematol. 2012 Oct;89(4):361-4. doi: 10.1111/j.1600-0609.2012.01832.x. Epub 2012 Aug 18. No abstract available.

PMID:
22775392
18.

Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

Monticone S, Hattangady NG, Nishimoto K, Mantero F, Rubin B, Cicala MV, Pezzani R, Auchus RJ, Ghayee HK, Shibata H, Kurihara I, Williams TA, Giri JG, Bollag RJ, Edwards MA, Isales CM, Rainey WE.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1567-72. doi: 10.1210/jc.2011-3132. Epub 2012 May 24.

19.

Ultraviolet activation of PKD: implications for skin cancer.

Bollag WB, Bollag RJ.

Future Oncol. 2011 Apr;7(4):485-7. doi: 10.2217/fon.11.16. No abstract available.

20.

Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders.

Voss KE, Bollag RJ, Fussell N, By C, Sheehan DJ, Bollag WB.

Arch Dermatol Res. 2011 Oct;303(8):591-600. doi: 10.1007/s00403-011-1136-x. Epub 2011 Mar 13.

21.

Transfusion considerations concerning patients with anti-hrB and confounding co-morbid conditions: pregnancy and coagulopathy.

Savage NM, Nugent WF, Devoe LD, Bollag RJ, Cook LO.

Blood Transfus. 2011 Apr;9(2):225-9. doi: 10.2450/2010.0029-10. Epub 2010 Dec 27. No abstract available.

22.

Wherefore art thou, YY1?

Bollag WB, Bollag RJ.

J Invest Dermatol. 2011 Jan;131(1):11-2. doi: 10.1038/jid.2010.322.

23.

Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.

Bollag RJ, Vender JR, Sharma S.

Neuropathology. 2010 Jun;30(3):279-87. doi: 10.1111/j.1440-1789.2009.01060.x. Epub 2009 Sep 14.

PMID:
19780983
24.

Lasp1 gene disruption is linked to enhanced cell migration and tumor formation.

Zhang H, Chen X, Bollag WB, Bollag RJ, Sheehan DJ, Chew CS.

Physiol Genomics. 2009 Aug 7;38(3):372-85. doi: 10.1152/physiolgenomics.00048.2009. Epub 2009 Jun 16.

25.

Targeted disruption of the Lasp-1 gene is linked to increases in histamine-stimulated gastric HCl secretion.

Chew CS, Chen X, Bollag RJ, Isales C, Ding KH, Zhang H.

Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G37-G44. doi: 10.1152/ajpgi.90247.2008. Epub 2008 May 15.

26.

Impact of glucose-dependent insulinotropic peptide on age-induced bone loss.

Ding KH, Shi XM, Zhong Q, Kang B, Xie D, Bollag WB, Bollag RJ, Hill W, Washington W, Mi QS, Insogna K, Chutkan N, Hamrick M, Isales CM.

J Bone Miner Res. 2008 Apr;23(4):536-43.

27.

Relapsed acute myelogenous leukemia occurring after 18 years with recurrent novel chromosomal abnormality t(18;22)(q23;q11.2).

Ustün C, Kalla A, Bollag RJ, Manaloo E, Kulharya A, Jillella A.

Cancer Genet Cytogenet. 2007 Sep;177(2):135-8.

PMID:
17854669
28.

Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.

Weinberger PM, Adam BL, Gourin CG, Moretz WH 3rd, Bollag RJ, Wang BY, Liu Z, Lee JR, Terris DJ.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):503-10.

PMID:
17515507
29.

Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass.

Xie D, Zhong Q, Ding KH, Cheng H, Williams S, Correa D, Bollag WB, Bollag RJ, Insogna K, Troiano N, Coady C, Hamrick M, Isales CM.

Bone. 2007 May;40(5):1352-60. Epub 2007 Jan 20.

PMID:
17321229
30.

Effects of glucose-dependent insulinotropic peptide on osteoclast function.

Zhong Q, Itokawa T, Sridhar S, Ding KH, Xie D, Kang B, Bollag WB, Bollag RJ, Hamrick M, Insogna K, Isales CM.

Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E543-8. Epub 2006 Sep 26.

31.

Effects of glucose-dependent insulinotropic peptide on behavior.

Ding KH, Zhong Q, Xie D, Chen HX, Della-Fera MA, Bollag RJ, Bollag WB, Gujral R, Kang B, Sridhar S, Baile C, Curl W, Isales CM.

Peptides. 2006 Nov;27(11):2750-5. Epub 2006 Jul 5.

PMID:
16822587
32.

Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover.

Xie D, Cheng H, Hamrick M, Zhong Q, Ding KH, Correa D, Williams S, Mulloy A, Bollag W, Bollag RJ, Runner RR, McPherson JC, Insogna K, Isales CM.

Bone. 2005 Dec;37(6):759-69. Epub 2005 Oct 10.

PMID:
16219496
33.

Carboxy-terminal PTH fragments stimulate [3H]thymidine incorporation in vascular endothelial cells.

Ding KH, Zhong Q, Xie D, Xu J, Bollag RJ, Bollag WB, Isales CM.

Peptides. 2005 May;26(5):853-62.

PMID:
15808916
34.

Multiple melanocortin receptors are expressed in bone cells.

Zhong Q, Sridhar S, Ruan L, Ding KH, Xie D, Insogna K, Kang B, Xu J, Bollag RJ, Isales CM.

Bone. 2005 May;36(5):820-31. Epub 2005 Mar 31.

PMID:
15804492
35.

Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development.

Harrelson Z, Kelly RG, Goldin SN, Gibson-Brown JJ, Bollag RJ, Silver LM, Papaioannou VE.

Development. 2004 Oct;131(20):5041-52.

36.

Tbx2 represses expression of Connexin43 in osteoblastic-like cells.

Chen JR, Chatterjee B, Meyer R, Yu JC, Borke JL, Isales CM, Kirby ML, Lo CW, Bollag RJ.

Calcif Tissue Int. 2004 Jun;74(6):561-73.

PMID:
15354864
37.

Tension-induced reduction in connexin 43 expression in cranial sutures is linked to transcriptional regulation by TBX2.

Borke JL, Yu JC, Isales CM, Wagle N, Do NN, Chen JR, Bollag RJ.

Ann Plast Surg. 2003 Nov;51(5):499-504.

PMID:
14595187
38.

Glucose-dependent insulinotropic peptide stimulates proliferation and TGF-beta release from MG-63 cells.

Zhong Q, Ding KH, Mulloy AL, Bollag RJ, Isales CM.

Peptides. 2003 Apr;24(4):611-6.

PMID:
12860206
39.

Negative transcriptional regulation of connexin 43 by Tbx2 in rat immature coronal sutures and ROS 17/2.8 cells in culture.

Borke JL, Chen JR, Yu JC, Bollag RJ, Orellana MF, Isales CM.

Cleft Palate Craniofac J. 2003 May;40(3):284-90.

PMID:
12733958
40.

1,25-Dihydroxyvitamin D(3), phospholipase D and protein kinase C in keratinocyte differentiation.

Bollinger Bollag W, Bollag RJ.

Mol Cell Endocrinol. 2001 May 25;177(1-2):173-82. Review.

PMID:
11377832
41.

Microarray analysis of Tbx2-directed gene expression: a possible role in osteogenesis.

Chen J, Zhong Q, Wang J, Cameron RS, Borke JL, Isales CM, Bollag RJ.

Mol Cell Endocrinol. 2001 May 25;177(1-2):43-54.

PMID:
11377819
42.

Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects.

Bollag RJ, Zhong Q, Ding KH, Phillips P, Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R, Isales CM.

Mol Cell Endocrinol. 2001 May 25;177(1-2):35-41.

PMID:
11377818
43.

Functional analysis of glucose-dependent insulinotropic polypeptide fusion proteins.

Ding KH, Isales CM, Zhong Q, Bollag RJ.

Peptides. 2001 Apr;22(4):575-82.

PMID:
11311726
44.

Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells.

Zhong Q, Bollag RJ, Dransfield DT, Gasalla-Herraiz J, Ding KH, Min L, Isales CM.

Peptides. 2000 Sep;21(9):1427-32.

PMID:
11072131
45.

Functional parathyroid hormone receptors are present in an umbilical vein endothelial cell line.

Isales CM, Sumpio B, Bollag RJ, Zhong Q, Ding KH, Du W, Rodriguez-Commes J, Lopez R, Rosales OR, Gasalla-Herraiz J, McCarthy R, Barrett PQ.

Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E654-62.

46.

Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors.

Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, Isales CM.

Endocrinology. 2000 Mar;141(3):1228-35.

PMID:
10698200
47.

Use of a repetitive mouse B2 element to identify transplanted mouse cells in mouse-chick chimeras.

Bollag RJ, Crawford KB, Stadt H, Kumiski D, Zdanowicz M, Baptista C, Herlea V, Kirby ML.

Exp Cell Res. 1999 Apr 10;248(1):75-8.

PMID:
10094814
48.

1,25-dihydroxyvitamin D3 induces phospholipase D-1 expression in primary mouse epidermal keratinocytes.

Griner RD, Qin F, Jung E, Sue-Ling CK, Crawford KB, Mann-Blakeney R, Bollag RJ, Bollag WB.

J Biol Chem. 1999 Feb 19;274(8):4663-70.

49.

Cloning and expression analysis of murine phospholipase D1.

Colley WC, Altshuller YM, Sue-Ling CK, Copeland NG, Gilbert DJ, Jenkins NA, Branch KD, Tsirka SE, Bollag RJ, Bollag WB, Frohman MA.

Biochem J. 1997 Sep 15;326 ( Pt 3):745-53.

50.

Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development.

Chapman DL, Garvey N, Hancock S, Alexiou M, Agulnik SI, Gibson-Brown JJ, Cebra-Thomas J, Bollag RJ, Silver LM, Papaioannou VE.

Dev Dyn. 1996 Aug;206(4):379-90.

Supplemental Content

Loading ...
Support Center